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The p53 tumor suppressor is a multifunctional protein, which regulates cell cycle, differentiation, DNA repair and apoptosis.
Experimentalseizuresup-regulatep53inthebrain,andacuteseizure-inducedneuronaldeathcanbereducedbygeneticdeletion
or pharmacologic inhibition of p53. However, few long-term functional consequences of p53 deﬁciency have been explored.
Here,weinvestigatedthedevelopmentofepilepsytriggeredbystatusepilepticusinwild-typeandp53-deﬁcientmice.Analysisof
electroencephalogram (EEG) recordings during status epilepticus induced by intra-amygdala kainic acid (KA) showed that
seizures lasted signiﬁcantly longer in p53-deﬁcient mice compared with wild-type animals. Nevertheless, neuronal death in the
hippocampal CA3 subﬁeld and the neocortex was signiﬁcantly reduced at 72h in p53-deﬁcient mice. Long-term continuous EEG
telemetry recordings after status epilepticus determined that the sum duration of spontaneous seizures was signiﬁcantly longer
in p53-deﬁcient compared with wild-type mice. Hippocampal damage and neuropeptide Y distribution at the end of chronic
recordingswasfoundtobesimilarbetweenp53-deﬁcientandwild-typemice.ThepresentstudyidentiﬁesprotractedKA-induced
electrographic status as a novel outcome of p53 deﬁciency and shows that the absence of p53 leads to an exacerbated epileptic
phenotype. Accordingly, targeting p53 to protect against status epilepticus or related neurologic insults may be offset by
deleterious consequences of reduced p53 function during epileptogenesis or in chronic epilepsy.
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Epilepsyisacommon,chronicneurologicdisordercharacterized
by recurrent seizures. Experimental modeling and human data
show that prolonged seizures (status epilepticus) or repeated
brief seizures over time can cause neuron loss, cognitive deﬁcits
and trigger or exacerbate epilepsy.
1,2 A variety of signaling
pathways have been implicated in seizure-induced neuronal
death, including those associated with apoptosis.
3 The tumor
suppressor p53 was one of the ﬁrst such genes implicated in
effecting seizure-induced neuronal death. In neurons, p53 is a
pleiotropic transcription factor which controls DNA repair, cell
cycle progression, differentiation and apoptosis.
4 Over-expres-
sion of p53 induces death of hippocampal neurons,
5,6 probably
via transcriptional induction of the pro-apoptotic Bcl-2 family
protein Puma.
7,8 Excitotoxic insults and prolonged seizures
up-regulate p53 in vivo,
9,10 and p53 levels are also elevated in
hippocampus from patients with long-standing temporal lobe
epilepsy.
11 Absence of p53 can prevent glutamate- and kainic
acid (KA)-induced death of cortical and hippocampal neurons
in vitro.
5 Moreover, p53-deﬁcient mice are protected acutely
againstseizure-inducedneuronaldeathinvivo
8,12,13andthep53
inhibitor piﬁthrin-a reduces seizure-induced neuronal death
in vitro and in vivo.
8,14,15
The question of whether neuroprotection has functional
antiepileptogenic consequences remains uncertain.
1 In some
studies, a reduction of hippocampal damage after status
epilepticusfailedtoblockthelateremergenceofepilepsy.
16,17
However, antiepileptogenic effects have been reported in
mice protected by epileptic pre-conditioning,
18 or genetic
deletion of puma.
8 Puma induction after status epilepticus is
p53-dependent,
8 so it is possible that loss of p53 would also
confer antiepileptogenic effects in the same model. However,
this may be offset by deregulation of p53-controlled functions
such as DNA repair, regulation of neurite branching and
axonal regeneration,
19,20 and, possibly, inhibitory neurotrans-
mission.
21 Interestingly, mice lacking p53 can display neuro-
degeneration
22 and worse outcomes after focal cerebral
ischemia.
23
In the present study, we sought to determine the functional
signiﬁcance of p53 in the pathogenesis of epilepsy by
characterizing the epileptic phenotype following status
epilepticus in mice lacking p53. Our data show that status
epilepticus in p53-deﬁcient mice have an altered electro-
encephalographic (EEG) proﬁle and result in a more severe
epileptic phenotype.
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Normal hippocampal architecture in p53-deﬁcient
mice. Before our analysis of their response to status
epilepticus, we examined brains from naı ¨ve wild-type and
p53-deﬁcient mice, as developmental defects in p53-
deﬁcient mice have been reported.
24,25 Inspection of
coronal brain sections stained for the neuronal nuclear
protein NeuN showed normal hippocampal architecture in
p53-deﬁcient mice (Figure 1a). Counts of pyramidal neurons
from a variety of subﬁelds revealed no differences in cell
numbers between wild-type and p53-deﬁcient mice
(Figure 1b). Next, we used western blotting to assess
levels of the KA receptor GluR6/7 to exclude potential
sources of variance in response to KA. Expression of GluR6/
7 in whole-cell lysates from the amygdala and hippocampus
was not different between wild-type and p53-deﬁcient mice
(Figure 1c).
Acute hippocampal CA3 and neocortical neuroprotection
after status epilepticus in p53-deﬁcient mice. We
recently reported that the hippocampal CA3 subﬁeld was
less damaged in p53-deﬁcient mice compared with wild-type
animals when status epilepticus was induced by intra-
amygdala KA.
8 To extend these data, we examined this
and other brain regions from wild-type and p53-deﬁcient mice
72h after status epilepticus in the same model. As reported,
8
p53-deﬁcient mice displayed signiﬁcantly less seizure-
induced neuronal death within the ipsilateral CA3 subﬁeld
after status epilepticus compared with wild-type animals
(Figure 2a and b). Analysis of the ipsilateral hilar region of the
dentate gyrus and the CA1 subﬁeld of the hippocampus in
wild-type animals found small and rather variable numbers of
degenerating neurons, as previously reported.
26 There was a
trend of neuroprotection in both ﬁelds in p53-deﬁcient
mice although this did not reach statistical signiﬁcance
(Figure 2c–f). In contrast, seizure-induced neuronal death
in the ipsilateral neocortex was also signiﬁcantly reduced in
p53-deﬁcient mice compared with wild-type animals (Figure
2g and h).
p53-regulated genes after status epilepticus in p53-
deﬁcient mice. We recently showed that induction of Puma,
a member of the BH3-only subgroup of pro-apoptotic Bcl-2
family proteins, was p53-dependent in the present model
and that Puma-deﬁcient mice were protected against
seizure-induced neuronal death.
8 We also established
that Noxa, another BH3-only protein regulated by p53, was
not induced.
8 Here, we analyzed hippocampal levels of
multidomain pro-apoptotic Bax and the BH3-only protein
Figure1 Normalbrainarchitectureinp53-deﬁcientmice.(a)RepresentativeNeuN-stainedsectionsfromnaı ¨vewild-type(wt)andp53-deﬁcient(p53
 / )brainsatthelevel
of dorsal hippocampus showing normal-appearing organization of neuronal populations. CA, cornu ammonis; DG, dentate gyrus. Scale bar, 400mm. (b) Graphs showing
average neuron counts from NeuN-stained sections of dorsal hippocampus from naı ¨ve brains for three major subﬁelds. No signiﬁcant differences were found for any subﬁeld
(n¼3 per group). (c) Representative western blots (n¼1 per lane) showing equivalent levels of the KA receptor GluR6–7 in the amygdala and hippocampus of each
genotype. Molecular weight markers in kilodaltons are depicted to the left. a-tubulin is included below as a guide to protein loading
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Cell Death and DiseaseBid, which are both under p53 control,
27,28 as well as the
seizure-regulated BH3-only protein Bim,
29 in wild-type and
p53-deﬁcient mice after status epilepticus. Bid, Bax and
Bim were not differently expressed in p53-deﬁcient mice
compared with wild-type mice after status epilepticus (see
Supplementary Figure, S1).
Prolonged electrographic seizures during status
epilepticus in p53-deﬁcient mice. Previous studies of
status epilepticus in p53-deﬁcient mice did not undertake
EEG analysis.
12,13 To establish whether or not p53-deﬁcient
mice underwent an episode of status epilepticus equivalent
to wild-type mice, we equipped animals from both
groups with skull-mounted electrodes and recorded
and quantiﬁed EEG between the time of KA microinjection
and administration of lorazepam to curtail seizures.
Unexpectedly, the sum duration of high amplitude and high
frequency electrographic seizures was signiﬁcantly longer in
p53-deﬁcient mice compared with wild-type mice (Figure 3a
and b).
Exacerbated epileptic phenotype in p53-deﬁcient
mice. We next sought to characterize the emergence and
phenotype of epilepsy in p53-deﬁcient mice. For this we used
Figure 2 Region-speciﬁc acute neuroprotection in p53-deﬁcient mice after status epilepticus.( a–h) Representative photomicrographs showing FJB staining of
degenerating neurons in various ipsilateral ﬁelds and corresponding graphs quantifying counts for wild-type (wt) and p53-deﬁcient (p53
 / ) mice 72h after status epilepticus.
Notethesigniﬁcantlyreducedneuronaldeathinp53
 / micein(a andb)CA3and(gandh)neocortex.Lensina, x40;lensinc, e,g, x20.Scalebar ina, 75mm;c( for c,e, g)
150mm. Data are from n¼10–20 per group. *Po0.05 compared to wt. ns, non-signiﬁcant
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Using this system we recently characterized the epileptic
phenotype following intra-amygdala KA-induced status
epilepticus in C57BL/6 mice.
26 Mice exhibit spontaneous
seizures 3 days following status epilepticus, with all mice
developing epilepsy by day 5. Mice typically display 1–4
spontaneous seizures per day.
26 To investigate whether
absence of p53 inﬂuences epilepsy in this model, we
implanted wild-type and p53-deﬁcient mice with EEG
telemetry units, subjected them to status epilepticus as
before, and then continuously recorded EEG beginning on
day 3 until the end of the second week post-status
epilepticus.
Representative EEG traces of spontaneous seizures
from telemetry recordings are shown in Figure 4a. The
emergent epileptic phenotype in wild-type mice was
Figure 3 Increased electrographic seizures after KA in p53-deﬁcient mice. (a) Graph showing sum of high amplitude and high frequency seizure time during status
epilepticus in wild-type (wt) and p53-deﬁcient (p53
 / ) mice (n¼8–12 per group). *Po0.05 compared with wild-type. (b) Representative traces of electrographic seizures
recorded after KA using surface electrodes in mice of each genotype. Note the extended polyspiking in p53
 /  mice
Figure 4 Increased spontaneousseizures and dissipationof hippocampal neuroprotection in p53-deﬁcientmice 2 weeks after status epilepticus. (a) Representative EEG
telemetry traces showing captured spontaneous seizures (spiking between arrows) in wild-type (wt) and p53-deﬁcient (p53
 / ) mice during epilepsy monitoring. (b) Graph
showing that the sum duration of spontaneous seizures in p53
 /  mice was signiﬁcantly longer than wt over the period of epilepsy monitoring. *Po0.05 compared with wild-
type(n¼6pergroup).(c)GraphshowingneuroncountsintheipsilateralCA3subﬁeldofmice2weeksafterstatusepilepticus.Wt(n¼7)andp53
 / (n¼6)micesubjectto
status epilepticus displayed signiﬁcantly reduced CA3 counts compared with control (Con) non-seizure wild-type mice (n¼2). CA3 counts between genotypes subject to
status epilepticus were non-signiﬁcant (ns). *Po0.05. (d) Representative NeuN-staining of the ipsilateral CA3 subﬁeld (x40 lens) from both genotypes 2 weeks after status
epilepticus. Note the similarity of neuronal survival within the CA3 subﬁelds. Scale bar, 75mm
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Cell Death and Diseaseessentially the same as that previously reported in this
model.
26 That is, all mice developed epilepsy within the ﬁrst
week following status epilepticus and averaged B2 sponta-
neous seizures per day. Individual spontaneous seizures
lasted just under 20s each. Monitoring of p53-deﬁcient mice
following status epilepticus determined that these mice also
all developed epilepsy. Further, over the 2-week recordings,
the sum duration of spontaneous seizures was signiﬁcantly
longer in p53-deﬁcient compared with wild-type mice
(Figure 4b). p53-deﬁcient mice tended to have more frequent
spontaneous seizures and the duration of a typical sponta-
neous seizure was B28% longer compared with wild-type
mice. Details of these and other measured parameters are
presented in the Supplementary Table (see Supple-
mentary Figure S2). Mice which received intra-amygdala
vehicle did not display any spontaneous seizures (n¼2, data
not shown).
Equivalence of hippocampal damage between wild-type
and p53-deﬁcient mice after long-term epilepsy
monitoring. On completion of the 2 weeks epilepsy
monitoring, brains from mice of both groups were
processed to assess hippocampal damage. Both wild-type
and p53-deﬁcient mice subjected to status epilepticus had
signiﬁcantly fewer surviving ipsilateral CA3 pyramidal
neurons compared with non-seizure vehicle-injected wild-
type mice (Figure 4c). However, p53-deﬁcient mice
subjected to status epilepticus did not have signiﬁcantly
different numbers of surviving CA3 neurons than wild-type
seizure mice (Figure 4c and d).
Neuropeptide Y re-organization in epileptic p53-deﬁcient
mice. Dentate gyrus rearrangement, including mossy ﬁber
sprouting is a common pathologic feature of temporal lobe
epilepsy. We next investigated changes to dentate gyrus
organization by staining hippocampal sections from the
epileptic mice for neuropeptide Y, which is a marker of
synaptic rearrangement.
Neuropeptide Y staining in non-seizure control mice was
mainly present in scattered hilar neurons and occasionally in
cells surrounding the stratum pyramidale layer. Diffuse low-
level staining was also evident in the outer molecular layer
of the dentate gyrus (Figure 5a). In contrast, neuropeptide Y
staining was markedly increased in the hippocampus of
epileptic wild-type mice (Figure 5a). This was most evident in
thestratum radiatum ofthe CA3apyramidal neurons (data not
shown) and in the outer molecular layer of the dentate gyrus
(Figure 5a and b). Neuropeptide Y staining in epileptic
p53-deﬁcient mice followed a similar pattern and semi-
quantitativeanalysisfoundnosigniﬁcantdifferencecompared
with wild-type mice (Figure 5a and b).
Figure 5 Neuropeptide Y rearrangement in p53-deﬁcient and wild-type mice
following status epilepticus. (a) Representative double-staining of NeuN (red) and
neuropeptide Y (NPY, green) of the dentate gyrus region in non-seizure control
wild-type mice (wtþveh), wild-type mice subject to status epilepticus (wtþSE)
and p53-deﬁcient mice subject to status epilepticus (p53
 / þSE). Note enhanced
NPY staining (green) in both genotypes subject to status epilepticus. DG, dentate
gyrus, mol, molecular layer. Scale bar, 300mm. (b) Graph showing NPY scores for
the dentate gyrus in sections taken following epilepsy monitoring. NPY was not
signiﬁcantly (ns) different between genotypes (n¼5–6 per group)
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Previous investigation of the role of p53 in epilepsy models
focused on putatively pro-apoptotic effects on acute seizure-
induced neuronal death. The present study conﬁrmed that
p53 regulates acute seizure-induced neuronal death in vivo,
and also shows that loss of p53 is associated with prolonged
electrographic status epilepticus and, chronically, develop-
ment of a more severe epileptic phenotype in mice. Thus, we
identify two novel consequences of p53 deﬁciency. This study
challenges the suitability of broad targeting of p53 for
neuroprotection and points to neurophysiologic and possibly
post-insult roles for p53, which may impact on the process of
epileptogenesis.
Thefunctionalsigniﬁcanceofp53foracuteseizure-induced
neuronal death is largely established. Induction of p53 is
commonly found in rodent brain following prolonged seizures,
while blocking p53 pharmacologically or genetically, spares a
signiﬁcant population of hippocampal neurons from degen-
eration.
9,10,12,14,30 In the present study, loss of p53 transiently
protected certain hippocampal neurons from status epilepticus
induced by intra-amygdala KA in mice, in accordance with our
previous ﬁndings,
8 and work by others.
12,13 We found, as in
other kainate models,
12 that p53-deﬁcient mice also display
reduced cortical neuronal death after status epilepticus. Thus,
p53 directly contributes to acute seizure-induced neuronal death
in vivo. The molecular mechanism of the protection probably
derives from inhibition of the BH3-only protein Puma. Indeed,
expression of Puma is blocked in p53-deﬁcient mice and
by piﬁthrin-a, and these mice are protected against status
epilepticus.
8 In contrast, while Bim-deﬁcient mice display
hippocampal neuroprotection in the present model,
29 Bim was
not differently expressed in p53-deﬁcient mice. Likewise, we
found that Bid, another p53-regulated BH3-only protein,
28 was
normally expressed in p53-deﬁcient mice, and loss of Bid does
not alter seizure-induced neuronal death in this model.
31 Thus,
Puma remains the most likely effector of p53-induced neuronal
death after status epilepticus in this model. Whether p73, a
homolog of p53, is important in the present model is unknown,
but p73 functions have been proposed to overlap with p53 in
regulating cell death.
32
The present study identiﬁed a novel neurophysiologic
phenotype resulting from the absence of p53. Mice lacking
p53 develop a more severe electrographic status epilepticus.
This contrasts with a previous study which, using behavioral
scoring, had reported that p53 deﬁciency does not inﬂuence
seizure severity.
12 This discrepancy highlightsthe importance
of using EEG as opposed to behaviour-only assessment to
grade status epilepticus. The present study did not explore
the cause of the phenotype. We did not ﬁnd any obvious
hippocampal or amygdala abnormalities in naı ¨ve p53-deﬁ-
cient mice, which could account for the observed effect,
although differences may exist at a cell structure or molecular
level. Indeed, p53 has been implicated in control of neurite
branching,
19 and a recent study identiﬁed a p53-dependent
gene which modulated seizure susceptibility and GABAA
(g-amino butyric acid) receptor expression.
21 Also, although
p53-deﬁcient mice are born normally,
33 loss of p53 has been
associated with decreased expression of a mitochondrial
enzyme,
34 developmental abnormalities,
25 brain tumors
12
and exencephaly.
24 It is also notable that mice lacking
effective DNA repair, a function under p53 control, display
earlier-onset KA-induced seizures.
15 The presence of a pro-
epileptic neurophysiologic phenotype in p53-deﬁcient mice
suggests it may be preferable to target genes under p53
control such as Puma rather than p53 itself to yield
neuroprotection.
8
Assessment of the longevity of hippocampal neuroprotect-
ion in p53-deﬁcient mice has produced conﬂicting ﬁndings.
Morrison et al. reported that protection against kainate
persisted in p53-deﬁcient mice for 1 week or longer,
12 while
Djebalietal.foundthatinitialprotectiveeffectswereabsentby
7 days after status epilepticus.
13 Here, we observed similar-
sized hippocampal lesions in p53-deﬁcient mice to wild-type
mice at the end of epilepsy monitoring. Thus, in our model, as
with Djebali et al., hippocampal cell loss in p53-deﬁcient mice
progressed to match the wild-type lesion. Although Djebali
et al. concluded delayed neuronal death must be
p53-independent
13 a secondary explanation is that the more
severe status epileticus in p53-deﬁcient mice was responsi-
ble. Notably, mice lacking the p53 target gene puma do not
display protracted seizures after KA and these mice continue
to display protection long after status epilepticus.
8 It is also
possible that spontaneous seizures in p53-deﬁcient mice
caused additional neuron loss thereby narrowing the differ-
ence with wild-type mice. However, spontaneous seizures
probably do not cause progressive neuron loss in epileptic
animals.
35 Loss of other functions of p53 may be accountable
for dissipation of neuroprotection over extended periods. p53
hasrolesinDNArepair,andeffectiveDNArepairmachineryis
important for protecting against seizure-damage.
15,36 Thus,
our data suggest that while acute seizure-induced neuronal
death comprises a p53-regulated component, the delayed
neuronal death in our model may be p53-independent or arise
from extended status epilepticus.
The present study also found that p53-deﬁcient mice
develop a more severe epileptic phenotype following status
epilepticus. This was unexpected. Indeed, other pharmaco-
logic or genetic neuroprotective manipulations using the
present model have translated to a reduction in the
occurrence of spontaneous seizures.
8,18 If unrelated to a
declining inﬂuence of the early neuroprotection, the exacer-
bated epileptic phenotype in p53-deﬁcient mice may be
the result of extended status epilepticus in these animals.
Indeed, in an opposite scenario where the duration of status
epilepticus was reduced, animals developed fewer sponta-
neous seizures.
37 Alternatively, loss of certain p53 functions
may have direct pro-epileptic consequences. Which
p53-regulated genes are responsible of course is unknown.
Post-injury axon outgrowth and regeneration may be altered
in p53-deﬁcient mice,
20 and we may speculate that p53
contributes to adaptive repair processes, which subvert
epileptic seizures. Deregulation of genes under p53 control
which have been implicated in inhibitory neurotransmission
21
might also be responsible. Regardless, the p53-dependent
process(es) disrupted presumably do not impact on gross
hippocampal changes which, at least when assayed by
neuropeptide Y rearrangement, were not different between
p53-deﬁcient and wild-type animals. Levels of p53 are
elevated in the epileptic focus of patients with temporal lobe
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11therefore,ratherthanbeinginterpretedasasignof
ongoing cell death, higher p53 levels might serve to inﬂuence
ictogenesis or other aspects of the epileptogenic process in
humans.
One caveat of the present study is that an inﬂuence of
genetic background cannot be entirely ruled out. Indeed,
when p53-deﬁcient mice were crossed to a non-C57BL/6
backgroundtheywerenolonger foundtobeprotected against
systemic KA.
38 In our model, however, damage variance
between genetic backgrounds is quite limited,
39 particularly
compared with the systemic KA model used in the earlier
report.
38
In summary, the present study revealed that, loss of p53
results in a neurophysiologic phenotype and exacerbated the
emergent epileptic phenotype following status epilepticus.
Given that p53 levels are altered in chronic human epilepsy,
thismay indicatea potentially antiepilepticroleforp53 beyond
its pro-apoptotic effects acutely. Wholesale targeting of p53
may be unsuitable for protection against status epilepticus,
but identiﬁcation, among the repertoire of genes under p53
control, of the cause of this phenotype may lead to potentially
novel antiepileptic or antiepileptogenic therapeutic targets.
Materials and Methods
Epilepsymodel. Allanimalprocedureswereperformedinaccordancewiththe
principals of the European Communities Council Directive (86/609/EEC) and were
approved by the Research Ethics Committee of the Royal College of Surgeons in
Ireland. Adult (20–25g) male mice were used and were obtained from Jackson
Laboratory, Bar Harbor, ME, USA (p53
þ/þ, /  on a C57BL/6 background).
Genotyping of mice was performed using DNA extracted from tail snips in
accordance with the supplier’s recommendations for Trp53
tm1Tyj (Jackson
Laboratory). Food and water were available ad libitum. Status epilepticus was
induced by unilateral stereotaxic microinjection of KA into the amygdala, as
described.
8 Brieﬂy, mice were ﬁrst anesthetized with isoﬂurane (3–5% induction,
1–2%maintenance)andkeptnormothermicina stereotaxicframe. Next,micewere
afﬁxed with skull-mounted electrodes (Bilaney Consultants Ltd., Sevenoaks, UK)
above thedorsal hippocampusand the frontalcortex to recordsurface EEG using a
Grass Comet digital EEG (Medivent Ltd., Lucan, Ireland). A guide cannula was
afﬁxed over the dura (coordinates from Bregma: AP¼ 0.94; L¼ 2.85mm) and
the entire skull assembly ﬁxed in place with dental cement. Anesthesia was
discontinued, EEG recordings were commenced, and then a 31-gauge internal
cannula was inserted into the lumen of the guide to inject KA (Ocean Produce
International, Nova Scotia, Canada) (0.3mg in 0.2ml vehicle; phosphate-buffered
saline (PBS), pH adjusted to 7.4) into the amygdala. Non-seizure control mice
received 0.2ml intra-amygdala vehicle. Lorazepam (6mg/kg, intraperitoneal) was
administered 40min after KA, and the EEG was recorded for up to 1h thereafter.
Mice were euthanized at different time points after anticonvulsant and brains
ﬂash-frozen whole in 2-methylbutane at  301C. Brains from additional naı ¨ve
(non-instrumented) wild-type and p53-deﬁcient mice were used to examine
hippocampal and amygdala neuroanatomy and gene expression.
Epilepsy monitoring. Long-term EEG recordings to deﬁne the emergence of
epilepsy was performed using implantable EEG telemetry units (Data Systems
International, St. Paul, MN, USA), as described.
8,18,26 Transmitters (Model: F20-EET,
DSI) were implanted in a subcutaneous pocket and used to record bilateral EEG from
skull overlying the dorsal ipsilateral and contralateral hippocampi. EEG data were
acquired using the Dataquest A.R.T. system. Following surgery, mice received intra-
amygdalaKAtoelicitstatus epilepticusandthentelemetryunitswereactivatedfromday
3 until day 14. After recordings, mice were euthanized and brains processed for
histopathology as described below. Telemetry EEG recordings were manually analyzed
for occurrence of epileptic seizures. These were deﬁned as high frequency (45Hz)
high amplitude (42  baseline) polyspike discharges of Z5s duration.
Western blotting. Western blotting was performed as previously described.
8
For analysis of naı ¨ve wild-type and p53-deﬁcient mice, both hippocampi or bilateral
amygdala tissue punches were obtained. For analysis of Bcl-2 family proteins after
seizures in wild-type and p53-deﬁcient mice, ipsilateral hippocampus was obtained
8h after lorazepam injection. Tissue was homogenized in a lysis buffer, proteins
boiled in gel-loading buffer, separated on SDS-PAGE gels and transferred onto
nitrocellulose membranes. Membranes were then incubated overnight with primary
antibodies against a-tubulin (Santa Cruz Biotechnology, Heidelberg, Germany), Bid
(R & D Systems Europe Ltd, Abingdon, UK), Bim (Enzo Life Sciences (UK) Ltd.,
Exeter, UK) and GluR6/7 (1:1000, Chemicon, Hampshire, UK). Membranes were
then incubated with horseradish peroxidase-conjugated secondary antibodies
(Jackson ImmunoResearch, Plymouth, PA, USA) and bands visualized using
Supersignal West Pico Chemiluminescent Substrate (Pierce, Rockford, IL, USA).
Images were captured using a Fuji-ﬁlm LAS-300 (Fuji, Shefﬁeld, UK) and
densitometry performed using AlphaEaseFC4.0 gel-scanning integrated optical
density software (Alpha Innotech, San Leandro, CA, USA).
Histopathology. Histopathology was undertaken as described.
8,26 For
assessment of acute neuronal damage, fresh-frozen brain sections at the level of
thedorsalhippocampuswereair-dried,post-ﬁxedinformalinandprocessedforFJB
staining (Millipore, Cork, Ireland). For immunohistochemistry, sections were ﬁrst
blocked in goat serum and then incubated overnight with NeuN (Chemicon) or
neuropeptideY(Sigma-AldrichIreland,Dublin,Ireland).Sectionswerethenwashed
and incubated with goat anti-mouse or goat anti-rabbit secondary antibodies
conjugated to AlexaFluor 488 or 568 (Bio Sciences Ltd., Dun Laoghaire, Ireland).
Sections were mounted and imaged using a Nikon 2000s epiﬂuorescence
microscope with a Hamamatsu Orca 285 camera (Micron-optica, Enniscorthy,
Ireland). Semi-quantiﬁcation of damaged and/or surviving cells was performed on
thesideipsilateraltoKAinjectionfortheentireCA3subﬁeld,beginningattheborder
with CA2 through to the end of CA3c/CA4, as well as the hilus, CA1 and neocortex.
Counts weretheaverageof twoadjacentsectionsassessedby an observerblinded
to experimental group/condition. Neuropeptide Y staining was used as a marker of
hippocampal re-organization. Staining was assessed on a semi-quantitative rating
scale accordingto previouslyreportedcriteria.
40 Brieﬂy,Score0, no neuropeptideY
between the tips and crest of the dentate gyrus; Score 1, sparse staining in the
supragranular region in a patchy distribution between the tips and crest of the
dentate gyrus; Score 2, more abundant neuropeptide Y in the supragranular region
in a continuous distribution between tips and crest of the dentate gyrus; Score 3,
prominent neuropeptide Y in the supragranular region in a continuous pattern
between tips and crest, with occasional patches of conﬂuent staining between
tips and crest of the dentate gyrus; Score 4, prominent neuropeptide Y in the
supragranular region that form a conﬂuent dense laminar band between tips and
crest and Score 5, conﬂuent dense laminar band of neuropeptide Y in the
supragranular region that extends into the inner molecular layer.
Data analysis. Data are presented as mean±S.E.M. Data were analyzed
using analysis of variance with post hoc Fisher’s PLSD test or for two group
comparisonStudent’st-test(StatViewsoftware;SASInstitute,Inc.,Cary,NC,USA).
Signiﬁcance was accepted at Po0.05.
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